IARS1 and Alzheimer disease: Initial evidence comes from a study showing that AD brains display markedly reduced levels of both insulin and insulin-like growth factors (IGF)-I and –II, accompanied by decreased expression of IR mRNA, IRS-associated PI3K, and activated Akt (Steen et al., 2005).